Your browser doesn't support javascript.
loading
Is there a role for novel TKI/ICI combinations in metastatic renal cell carcinoma? Definitely maybe.
Meza, L; Bergerot, P G; Agarwal, N; Pal, S K.
Afiliación
  • Meza L; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA.
  • Bergerot PG; Department of Medical Oncology, Cettro Cancer Center, Brasilia, Brazil.
  • Agarwal N; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.
  • Pal SK; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA. Electronic address: spal@coh.org.
Ann Oncol ; 32(1): 12-14, 2021 01.
Article en En | MEDLINE | ID: mdl-33121996
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos